switching from glp 1 to tirzepatide Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis Switching between weight-loss medications -

Also, consider talking with a registered dietitian who can help you determine the appropriate balance of soluble and insoluble fiber for you

Clinical trials demonstrate that weight loss continues or stabilizes with ongoing tirzepatide use, with patients in the SURMOUNT trials maintaining significant weight reduction at 72 weeks

If youre tired of guessing, medical support can help you focus on what actually moves the needle: appetite regulation, steady habits, and accountability

Most exposures were to liraglutide and semaglutide rather than tirzepatide specifically

These insights may help provide context for predicting fatigue likelihood and tailoring dosing strategies